Zobrazeno 1 - 10
of 484
pro vyhledávání: '"W. Blau"'
Autor:
Marion Larue, Myriam Labopin, Thomas Schroeder, Xiao‐jun Huang, Igor W. Blau, Johannes Schetelig, Arnold Ganser, Rose‐Marie Hamladji, Wolfgang Bethge, Nicolaus Kröger, Gerard Socié, Urpu Salmenniemi, Henrik Sengeloev, Bhagirathbhai Dholaria, Bipin N. Savani, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Publikováno v:
HemaSphere, Vol 8, Iss 10, Pp n/a-n/a (2024)
Abstract Information on late complications in patients with acute leukemia who have undergone allogeneic hematopoietic cell transplantation (HCT) is limited. We performed a left‐truncated analysis of long‐term survival in patients with acute leuk
Externí odkaz:
https://doaj.org/article/09c3faec71ba4764a35435dfe6de6cda
Autor:
Elias K. Mai, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja C. Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W. Blau, Mathias Hänel, Hans J. Salwender, Axel Benner, Marc S. Raab, Hartmut Goldschmidt, Niels Weinhold
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Mass spectrometry (MS) is a promising tool for monitoring monoclonal protein in plasma cell dyscrasias. We included 480 transplant-eligible newly-diagnosed multiple myeloma (MM) patients from the GMMG-MM5 trial (EudraCT No. 2010-019173-16) a
Externí odkaz:
https://doaj.org/article/1275a2059f114b41a54bedff8ec0c75f
Autor:
Jan Frederic Weller, Claudia Lengerke, Jürgen Finke, Johannes Schetelig, Uwe Platzbecker, Hermann Einsele, Thomas Schroeder, Christoph Faul, Matthias Stelljes, Peter Dreger, Igor W. Blau, Gerald Wulf, Johanna Tischer, Christoph Scheid, Ahmet Elmaagacli, Helga Neidlinger, Sarah Flossdorf, Martin Bornhäuser, Wolfgang Bethge, Katharina Fleischhauer, Nicolaus Kröger, Liesbeth C. de Wreede, Maximilian Christopeit
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Incidences of diseases treated with transplantation frequently peak at higher age. The contribution of age to total risk of transplantation has not been estimated amidst an aging society. We compare outcomes of 1,547 patients aged 70-79 years and 9,4
Externí odkaz:
https://doaj.org/article/fc1be0b091ba420e8bdda5a14ed93bf6
Autor:
J. Schrezenmeier, J. E. Straeng, O. Blau, A. Elashy, A. Lazarides, S. Skambraks, E. Jahn, B. Gillißen, C. Eckert, A. Nogai, I.-W. Blau, K. Giannopoulos, M. Heuser, K. Döhner, L. Bullinger, A. Dolnik
Publikováno v:
HemaSphere, Vol 6, Pp 356-357 (2022)
Externí odkaz:
https://doaj.org/article/a4468a0afc954b8480d18e9a6a4f86cb
Autor:
S. Huhn, A. M. Poos, E. K. Mai, M. Hänel, H. J. Salwender, J. Dürig, I. W. Blau, C. Scheid, K. C. Weisel, M. Munder, O. Berlanga, U. Bertsch, H. Goldschmidt, N. Weinhold
Publikováno v:
HemaSphere, Vol 6, Pp 771-772 (2022)
Externí odkaz:
https://doaj.org/article/402d78268cb74960ad8fc2340e8cbae1
Autor:
E. Tranter, B. Obermayer-Wasserscheid, M.-L. Hütter-Krönke, C. Junkuhn, I.-W. Blau, G. L. Vuong, L. Bullinger, I.-K. Na
Publikováno v:
HemaSphere, Vol 6, Pp 1494-1495 (2022)
Externí odkaz:
https://doaj.org/article/9dd8d0d294f14bbea20293bf8e13fc18
Autor:
Niels Weinhold, Hans J. Salwender, David A. Cairns, Marc S. Raab, George Waldron, Igor W. Blau, Uta Bertsch, Thomas Hielscher, Gareth J. Morgan, Anna Jauch, Faith E. Davies, Mathias Hänel, Gordon Cook, Christoph Scheid, Richard Houlston, Hartmut Goldschmidt, Graham Jackson, Martin F. Kaiser
Publikováno v:
Haematologica, Vol 106, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/3365e5937a4949ab8d07cde012cd6922
Autor:
Hans Salwender, Uta Bertsch, Katja Weisel, Jan Duerig, Christina Kunz, Axel Benner, Igor W. Blau, Marc Steffen Raab, Jens Hillengass, Dirk Hose, Stefanie Huhn, Michael Hundemer, Mindaugas Andrulis, Anna Jauch, Andrea Seidel-Glaetzer, Hans-Walter Lindemann, Manfred Hensel, Stefan Fronhoffs, Uwe Martens, Timon Hansen, Mohammed Wattad, Ullrich Graeven, Markus Munder, Roland Fenk, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Despite major advances in therapy, multiple myeloma is still an incurable malignancy in the majority of patients. To increase survival, deeper remissions (i.e. CR) translating into longer PFS need to be achieved. Incorporation of
Externí odkaz:
https://doaj.org/article/5f886bfc9cbd44f2ba2caaa95f24d69d
Autor:
Olaf Penack, Christophe Peczynski, Steffie van der Werf, Jürgen Finke, Arnold Ganser, Helene Schoemans, Jiri Pavlu, Riitta Niittyvuopio, Wilfried Schroyens, Leylagül Kaynar, Igor W. Blau, Walter van der Velden, Jorge Sierra, Agostino Cortelezzi, Gerald Wulf, Pascal Turlure, Montserat Rovira, Zubeydenur Ozkurt, Maria J. Pascual-Cascon, Maria C. Moreira, Johannes Clausen, Hildegard Greinix, Rafael F. Duarte, Grzegorz W. Basak
Publikováno v:
Haematologica, Vol 105, Iss 7 (2020)
Uric acid is a danger signal contributing to inflammation. Its relevance to allogeneic stem cell transplantation (alloSCT) derives from preclinical models where the depletion of uric acid led to improved survival and reduced graft-versus-host disease
Externí odkaz:
https://doaj.org/article/014b3334707f4920ab63efcacd76b81a
Autor:
Sihe Jiang, Olaf Penack, Tobias Terzer, David Schult, Joshua Majer-Lauterbach, Aleksandar Radujkovic, Igor W. Blau, Lars Bullinger, Carsten Müller-Tidow, Peter Dreger, Thomas Luft
Publikováno v:
Haematologica, Vol 106, Iss 2 (2020)
No biomarker panel is established for prediction of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD), a major complication of allogeneic stem cell transplantation (alloSCT). We compared the potential of the Endothelial Activation and
Externí odkaz:
https://doaj.org/article/96f964b10e61477bb5c92932fb0cafd7